NEW YORK, NY — On December 15, 2025, Impiricus, a leader in AI-powered healthcare engagement, was spotlighted on the iconic Nasdaq Tower in Times Square. The feature marks a historic milestone for the company, celebrating its unprecedented 30,000% growth over the last few years and its role as the new standard-bearer for ethical AI in clinical support.
The recognition comes at a time when Impiricus is fundamentally shifting how historically underserved physicians interact with pharmaceutical resources. Through its AI innovation, Impiricus is accelerating access to treatment for patients while providing an unprecedented level of clinical support to the providers who need it most.
“Seeing Impiricus light up Times Square is a testament to our team’s relentless dedication to solving the most critical gaps in healthcare,” said Osama, Co-founder and CEO of Impiricus. “As a physician, I see the gaps in our healthcare system every day and I know firsthand the challenges of keeping pace with medical innovation. I built Impiricus to bridge those gaps using ethical AI, providing clinical support to historically underserved physicians and ensuring that patients, no matter where they are, get faster access to the treatments they need. We’ve grown 30,000% over the last few years, but our North Star remains the same: empowering doctors with innovation that delivers the best possible care to their patients.”
The Nasdaq feature coincides with a period of massive momentum as the company prepares for further expansion in 2026. This trajectory is fueled by a commitment to ethical AI frameworks that prioritize clinical accuracy and physician trust—a move that has resonated deeply across the healthcare landscape.
“Scaling 30,000% in just a few years doesn’t happen by accident. It happens when you align a world-class team with a mission to solve the industry’s most pressing challenges,” said Sandy, Co-founder and Chief of Strategy. “We are ensuring that life-changing treatments reach patients faster and more equitably. We aren’t just participating in the market, we’re redefining it and we’re headed into a massive 2026.”
